Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin conjugating enzyme E2 L2 (UBE2L2)
- Target
- UBE2L2
- Molecular classification
- Pseudogene (not an active enzyme)
01
Overview
UBE2L2 (ubiquitin conjugating enzyme E2 L2) is a pseudogene in humans homologous to the ubiquitin conjugating enzyme E2 L1 (UBE2L1). Unlike bona fide E2 enzymes involved in protein ubiquitination, UBE2L2 does not encode a functional protein or exhibit documented biological activity in human cells. As a result, it is not considered a therapeutic target or involved in disease roles, drug mechanisms, or standard molecular classification schemes for protein targets.
- Other names
- Ubiquitin conjugating enzyme E2L2L-UBC pseudogeneHomologous to UBE2L1
02
Mechanism of action
Not applicable—no active protein, so no mechanism of action is available
03
Biological functions
Lacks biological function as a protein in humans due to being a pseudogene
04
Disease associations
No known association as a disease target (not expressed as a protein)
05
Safety considerations
No safety concerns, since it does not produce a protein or active molecular target
06
Interacting drugs
No drugs interact with this entity since it does not produce functional protein
07
Biomarkers
Not used as a biomarker for selection or efficacy monitoring
Beyond the preview
Go deeper on Ubiquitin conjugating enzyme E2 L2 (UBE2L2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ubiquitin conjugating enzyme E2 L2 (UBE2L2).